Skip to main content
. 2002 Jun 5;86(11):1697–1700. doi: 10.1038/sj.bjc.6600346

Figure 1.

Figure 1

Changes in left ventricular ejection (LVEF) during doxorubicin therapy. (A) represents data of all patients, and (B) represents data without and with the decrease in LVEF ⩾10% units to the final LVEF ⩽50%. *P<0.05, ** P<0.01, ***P<0.001 vs baseline.